Descriptions:
Term | description type | Language/acceptability | Language/acceptability | Case Significance |
---|---|---|---|---|
Allergy to [substance or product] (finding) | FSN | us:P | gb:P | ci |
Allergy to [substance or product] | SYN | us:P | gb:P | ci |
[substance or product] allergy | SYN | us:A | gb:A | ci |
Concept model:
Attribute Group Cardinality | Attribute Cardinality | Attribute in Group Cardinality | Attribute | Value |
---|---|---|---|---|
1..1 | 0..0 | |||
1..1 | 1..1 | |||
1..1 |
Definition status:
900000000000073002 |Defined (core metadata concept)|
Applies to:
<
609328004 |Allergic disposition (finding)|
EDITORIAL GUIDELINES for Causative agent (attribute):
Hierarchy | Concept type | Allowed | Exception | Examples and Notes |
---|---|---|---|---|
Substance | Base substance | yes | none | Allergy concepts representing a substance base should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|. Example:
Expected classification (Agreed 21-Jan-2020):
|
Substance | Modification | no | yes | Example: 293908005 |Allergy to chloral hydrate (finding)| Chloral hydrate is a sedative and may not be well-represented by "Chloral derivative". Expected classification (Agreed 21-Jan-2020):
|
Substance | Disposition grouper | yes | none | Example:
Expected classification results (Agreed 21-Jan-2020):
|
Substance | Structure grouper | yes | none | Example:
Expected classification (Agreed 21-Jan-2020):
|
Substance | Role grouper | no | none | Role groupers in the Substance hierarchy will be inactivated in a future release and should not be used for modeling in this subhierarchy. (Agreed 21-Jan-2020) |
Product | Disposition grouper | no | none | No use case has been identified for use of this concept type for modeling in this subhierarchy. Disposition groupers in the Product hierarchy should only exist as SD concepts with a corresponding concept in the Substance hierarchy; the corresponding concept in the Substance hierarchy should be used for modeling in this subhierarchy. (Agreed 21-Jan-2020) |
Product | Structure grouper | no | none | No use case has been identified for use of this concept type for modeling in this subhierarchy. Structure groupers in the Product hierarchy should only exist as SD concepts with a corresponding concept in the Substance hierarchy; the corresponding concept in the Substance hierarchy should be used for modeling in this subhierarchy. (Agreed 21-Jan-2020) |
Product | Role grouper | yes | none | Example: 417930000 |Allergy to adhesive agent (finding)|
|
Product | Medicinal product-containing | yes | none | Example:
Expected classification results: NEEDS INTERNAL AGREEMENT
https://confluence.ihtsdotools.org/display/IAP/Allergy+to+X+vaccine |
Product | Medicinal product-only | no | none | No use case has been identified for use of this concept type for modeling in this subhierarchy. Medicinal product-containing concepts can be used for modeling in this subhierarchy. (Agreed 21-Jan-2020) |
Product | Medicinal product form-containing | no | none | No use case has been identified for use of this concept type for modeling in this subhierarchy. Medicinal product form-containing concepts can be used for modeling in this subhierarchy. (Agreed 21-Jan-2020) |
Product | Medicinal product form-only | no | none | No use case has been identified for use of this concept type for modeling in this subhierarchy. Medicinal product form-containing concepts can be used for modeling in this subhierarchy. (Agreed 21-Jan-2020) |
Product | Clinical drug | no | none | No use case has been identified for use of this concept type for modeling in this subhierarchy. Medicinal product form-containing concepts can be used for modeling in this subhierarchy. (Agreed 21-Jan-2020) |
Template language
420134006 |Propensity to adverse reactions (finding)| : [[~1..1 @rolegroup]] { [[~1..1]] 719722006 |Has realization (attribute)| = 472964009 |Allergic process (qualifier value)| , [[~1..1]] 246075003 |Causative agent (attribute)| = [[ +id (< 105590001 |Substance (substance)| OR < 373873005 |Pharmaceutical / biologic product (product)| ) @causative]] }
Misalignment report:
https://docs.google.com/spreadsheets/d/1CUWI2KYdfjj2MuFTLif1AzCk8BaFYpNN0738F5gJvdk/edit#gid=0
Rules for description generation:
- Remove the semantic tag, e.g. (body structure)
- Remove 'Structure of' from [body structure] if term starts with 'Structure of' e.g. 709530002|Structure of phalanx of hand (body structure)|
- Remove 'structure' from [body structure] if term contains 'structure', e.g. 69536005|Head structure (body structure)| 24097009|Bone structure of hand (body structure)|
JIRA ticket for implementation:
- INFRA-11601Getting issue details... STATUS
7 Comments
Farzaneh Ashrafi
Hi Yongsheng Gao
Following the QI Call discussion relating to https://docs.google.com/spreadsheets/d/1Hc0rCWYkT4Uo6rpodF-P8DXg2-42apV1Ws6nRh5e3DY/edit#gid=2, I have updated "Applies to:" section to "< 609328004 |Allergic disposition (finding)|".
Please let me know if any additional change is required.
Thanks,
Farzaneh
Yongsheng Gao
Hi Farzaneh Ashrafi I have updated the format of cardinality. The range of "causative agent" is restricted to the descendants and excludes Substance and Pharmaceutical / biologic product (product). Please let me know if any further changes are needed.
Farzaneh Ashrafi
Thanks Yongsheng Gao . No additional changes are needed at this point.
Peter G. Williams
Yongsheng Gao does this template need to be ticketed for transition to Production? Version 2.0 that's currently in there references concepts that are no longer active. Thanks!
Yongsheng Gao
Hi Peter G. Williams The ticket for updating to v.30 is in the link TBBA-472 for the technical team.
Nicola Ingram
Farzaneh Ashrafi has an action to review relevant templates in the light of the roles grouper consultation - results being published next week.
cc Yongsheng Gao
Farzaneh Ashrafi
Hi Nicola Ingram
The changes to the templates is just about the editorial guidelines for causative agent. Specifically for this one, no change is needed. The implementation of the template can go ahead.
Thanks,
Farzaneh
CC: Yongsheng Gao Peter G. Williams